ImmuCell Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 30, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	54	46	39	47	62	43
Market Cap Growth	15.51%	16.33%	-16.51%	-23.70%	44.31%	15.59%
Enterprise Value	64	58	54	51	62	48
Last Close Price	6.02	5.15	5.09	6.10	8.00	5.95
PE Ratio	23.32	-	-	-	-	-
PS Ratio	1.95	1.73	2.26	2.55	3.22	2.80
PB Ratio	1.83	1.67	1.58	1.56	1.90	1.52
P/TBV Ratio	1.83	1.68	1.59	1.56	1.91	1.53
P/FCF Ratio	76.12	-	-	-	-	-
P/OCF Ratio	27.37	128.23	-	-	64.91	32.62
EV/Sales Ratio	2.31	2.17	3.10	2.76	3.22	3.13
EV/EBITDA Ratio	11.81	39.63	-	65.78	22.78	49.62
EV/EBIT Ratio	23.46	-	-	-	240.62	-
EV/FCF Ratio	89.71	-	-	-	-	-
Debt / Equity Ratio	0.46	0.55	0.67	0.41	0.32	0.38
Debt / EBITDA Ratio	2.29	7.75	-	12.96	3.57	9.69
Debt / FCF Ratio	19.02	-	-	-	-	-
Asset Turnover	0.62	0.60	0.39	0.42	0.45	0.39
Inventory Turnover	1.85	2.43	1.89	2.26	4.09	3.68
Quick Ratio	1.63	1.72	0.76	2.47	5.09	4.44
Current Ratio	4.21	3.41	2.73	4.56	6.42	5.50
Return on Equity (ROE)	8.27%	-8.21%	-20.86%	-7.92%	-0.26%	-3.57%
Return on Assets (ROA)	3.79%	-1.73%	-7.36%	-2.39%	0.38%	-2.18%
Return on Invested Capital (ROIC)	7.00%	-3.10%	-13.43%	-4.90%	0.81%	-4.62%
Return on Capital Employed (ROCE)	6.60%	-3.00%	-13.20%	-4.10%	0.60%	-3.60%
Earnings Yield	4.27%	-4.70%	-14.64%	-5.28%	-0.13%	-2.38%
FCF Yield	1.31%	-0.24%	-16.64%	-11.68%	-2.67%	-6.42%
Buyback Yield / Dilution	-14.38%	-5.42%	-0.03%	-2.01%	-5.25%	-5.78%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q